Lipitor and Cefpodoxime proxetil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Cefpodoxime proxetil (cefpodoxime proxetil). Common drug interactions include death among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Cefpodoxime proxetil. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Cefpodoxime proxetil?

Cefpodoxime proxetil has active ingredients of cefpodoxime proxetil. eHealthMe is studying from 1,357 Cefpodoxime proxetil users. Check the latest studies of Cefpodoxime proxetil.



On Jul, 05, 2026

36 people who take Lipitor and Cefpodoxime proxetil together, and have interactions are studied.

Lipitor and Cefpodoxime proxetil drug interactions.

What are the common drug interactions of Lipitor and Cefpodoxime Proxetil, by gender? *:

female:

  1. Death
  2. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  3. Deformity (disfigurement)
  4. Depression
  5. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  6. Dizziness
  7. Dry mouth
  8. Duodenitis (inflammation of the duodenum)
  9. Dysarthria (speech disorder)
  10. Dysgeusia (disorder of the sense of taste)

male:

  1. Death
  2. Abdominal pain upper
  3. C-reactive protein increased
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Chondropathy (disease of the cartilage)
  6. Confusional state
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Drug ineffective
  9. Erectile dysfunction
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Lipitor and Cefpodoxime Proxetil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain upper
  2. Chondropathy (disease of the cartilage)
  3. Confusional state
  4. Fatigue (feeling of tiredness)
  5. Frequent bowel movements
  6. Memory impairment
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Myalgia (muscle pain)
  9. Pain in extremity

50-59:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Herpes zoster

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Infection
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hot flush (sudden feelings of heat)
  5. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  6. Tumour marker increased
  7. Urinary tract infection
  8. White blood cell count decreased
  9. Death
  10. Rash

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 22.22%
  2. High Blood Pressure: 6 people, 16.67%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 16.67%
  4. Pain: 6 people, 16.67%
  5. Pneumonia: 4 people, 11.11%
  6. Breast Cancer Metastatic: 4 people, 11.11%
  7. Asthma: 3 people, 8.33%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.33%
  9. Diabetes: 3 people, 8.33%
  10. Blood Pressure Abnormal: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Cefpodoxime proxetil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipitor and Cefpodoxime proxetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefpodoxime proxetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefpodoxime proxetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and cefpodoxime proxetil (the active ingredients of Lipitor and Cefpodoxime proxetil, respectively), and Lipitor and Cefpodoxime proxetil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: